Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (371-380 of 551) with videos related to

Pageof 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancerF V Fossella, S M Lippman, D M Shin, et al.
NPJ Precision Oncology|September 22, 2022
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapyBryan H Louie, Shumei Kato, Ki Hwan Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2011
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survivalW N William, J-S Kim, D D Liu, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in UrineHatim Husain, Vladislava O Melnikova, Karena Kosco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2012
Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic studyXia Pu, Yuanqing Ye, Margaret R Spitz, et al.
Cancer|March 11, 2008
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor featuresMahitosh Mandal, Jeffery N Myers, Scott M Lippman, et al.
Lancet (London, England)|October 18, 2005
Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control studyJ Sudbø, J J Lee, S M Lippman, et al.
Pageof 56

Showing results (371-380 of 551) with videos related to

Sort By:
Pageof 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancerF V Fossella, S M Lippman, D M Shin, et al.
NPJ Precision Oncology|September 22, 2022
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapyBryan H Louie, Shumei Kato, Ki Hwan Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2011
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survivalW N William, J-S Kim, D D Liu, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in UrineHatim Husain, Vladislava O Melnikova, Karena Kosco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2012
Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic studyXia Pu, Yuanqing Ye, Margaret R Spitz, et al.
Cancer|March 11, 2008
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor featuresMahitosh Mandal, Jeffery N Myers, Scott M Lippman, et al.
Lancet (London, England)|October 18, 2005
Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control studyJ Sudbø, J J Lee, S M Lippman, et al.
Pageof 56